Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABT-335 (Trilipix) Reverse Cholesterol Transport Study
NCT00673881Phase 2Completed
- Sponsor
- Radiant Research
- Start
- Mar 2008
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of fenofibric acid in dyslipidemia, sponsored by Radiant Research. Primary endpoints: Mean Change in Calculated Low Density Lipoprotein Cholesterol at 12 weeks, Mean Change in Plasma Triglycerides at 12 weeks and 2 more. Started Mar 2008; status: completed.
02
Drugs
fenofibric acid
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on NCT00673881.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00673881.